John Galvin Jr., MD, Oncology, Chicago, IL, University of Illinois Hospital & Health Sciences System

JohnPatrickGalvinJr.MD

Oncology Chicago, IL

Hematologic Oncology

Assistant Professor - Hematology/Oncology, Blood & Marrow Transplant, Immunology - University of Illinois

Dr. Galvin is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Galvin's full profile

Already have an account?

Summary

  • Dr. John Galvin is an hematologist in Chicago, IL and is affiliated with University of Illinois Cancer Center. He has been in practice 11 years. He specializes in hematologic oncology with a focus on stem cell transplantation and graft versus host disease.

Education & Training

  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityFELLOWSHIP
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityFELLOWSHIP
  • Mount Sinai School of Medicine
    Mount Sinai School of MedicineRESIDENCY
  • University of Illinois College of Medicine
    University of Illinois College of MedicineMEDICAL_SCHOOL

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2009 - 2020
  • NY State Medical License
    NY State Medical License 2008 - Present
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Role of Racial, Demographic and Socioeconomic Disparities in Treatment Patterns and Outcomes in AML
    John P Galvin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Disease Progression, Hospital Readmissions, and Clinical Outcomes of Patients with Steroid-Refractory Acute Graft-Versus-Host Disease: A Multicenter Chart Review
    John P Galvin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Low Pre-Treatment Hemoglobin and Creatinine Clearance Correlate with Worse Overall Survival, Treatment-Related Mortality, and Regimen-Related Toxicities in Patients Un...
    John P Galvin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Searching for lymphoma: An analysis of internet and social network activity and engagement. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Use of a Processed Hematopoietic Stem Cell Product (FCRx) in Unmatched Related and Unrelated Donor – Recipient Pairs Is Associated with High Levels of Donor Chimerism ... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Limitations to Receiving Allogeneic Hematopoietic Cell Transplantation for Treatment of Acute Myeloid Leukemia: A Large Multi-Center Prospective Longitudinal Observati... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Professional Memberships

Hospital Affiliations